• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Daily Derm Times: February 21, 2025

Key Takeaways

  • Vitiligo patients have a higher COVID-19 incidence than those with psoriasis or atopic dermatitis, indicating potential immune system implications.
  • Low-fluence Q-switch laser and tranexamic acid effectively reduce postinflammatory hyperpigmentation, especially in darker skin tones.
SHOW MORE

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times logo

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Patients with DIMIDs and Pandemic Risks

A study found that vitiligo patients had a higher incidence of COVID-19 than those with psoriasis or atopic dermatitis.

Low-Fluence Q-Switch Laser and Tranexamic Acid Can Quickly Treat Postinflammatory Hyperpigmentation

The combination treatment safely and quickly reduced laser-induced hyperpigmentation, especially on darker skin tones.

DELTA TEEN Highlights Potential of Delgocitinib in Adolescents With Chronic Hand Eczema

The phase 3 clinical trial investigating delgocitinib cream for adolescents with moderate to severe CHE met its primary and key secondary endpoints.

Study Reveals Majority of US Adults Distrust Health Care System’s Use of AI

A study found that 65.8% of US adults distrust their health care system’s use of AI, highlighting a need for better communication on AI tools.

Dermatological Impact of Martian Space Travel

Geological particles can cause skin irritation, allergies, and long-term dermatological conditions.

Oral Cicaglocal is an Effective Treatment for Post-Mohs Wound Healing

Satisfaction levels rose and recovery outcomes greatly improved with Cicaglocal compared to the placebo.

Related Videos
infectious disease
© 2025 MJH Life Sciences

All rights reserved.